We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Abbott Diagnostics division of Abbott Laboratories received a warning letter after an FDA inspection found its diagnostic analyzers were adulterated due to good manufacturing practice violations.
Medicare paid contractors approximately $700 million in improper payments for durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) between April 2005 and April 2006, the Government Accountability Office (GAO) said in a recent report.
The Gender Solutions Knee from Zimmer is the only knee replacement designed to accommodate the anatomical differences in a woman's knee and is now available at the Mount Sinai School of Medicine, the school announced.
Reps. Albert Wynn (D-Md.) and Kay Granger (R-Texas) introduced legislation providing funding for colorectal cancer screenings, particularly for low income and uninsured individuals.
Researchers are urging more comprehensive imaging for patients with stroke symptoms after a recent study showed magnetic resonance imaging (MRI) and echocardiography together improve detection of cause and selection of treatment for cardioembolic strokes, the "meanest" type of stroke, according to the Society of Interventional Radiology (SIR).
CryoCath Technologies announced the FDA is allowing it to expand its investigational device trial of its Arctic Front to the full cohort of patients in 20 centers.
Boston Scientific's "largest driver in financial performance" is the drug-eluting stent market, which has been softening, with "no rebound" seen yet, Chief Operating Officer Paul LaViolette said at the Lehman Brothers 10th Annual Global Healthcare Conference.